Fibromyalgia and cytokines

Immunology Letters

Volumn 161, Issue 2, 2014, Pages 200-203

  Rodriguez Pintó, Ignasi ^a,b   Agmon Levin, Nancy ^a,c   Howard, Amital ^a   Shoenfeld, Yehuda ^a,c  

^a SHEBA MEDICAL CENTER   (Israel)

^b HOSPITAL CLÍNIC   (Spain)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Biologic markers; Chemokines; Cytokines; Fibromyalgia; Pain

Indexed keywords

CHEMOATTRACTANT; CHEMOKINE; CYTOKINE; EOTAXIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; AUTACOID;

ARTICLE; CHRONIC PAIN; FIBROMYALGIA; GLIA CELL; HUMAN; IMMUNE SYSTEM; MONONUCLEAR CELL; PATHOGENESIS; PRIORITY JOURNAL; SYMPATHETIC TONE; SYNAPTIC TRANSMISSION; IMMUNOLOGY; METABOLISM;

CHEMOKINES; CYTOKINES; FIBROMYALGIA; HUMANS; INFLAMMATION MEDIATORS;

EID: 84906794898     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2014.01.009     Document Type: Article

References (32)

1. Wolfe F., Clauw D.J., Fitzcharles M-A., Goldenberg D.L., Katz R.S., Mease P., et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken) 2010, 62:600-610.
2. Wolfe F., Smythe H.A., Yunus M.B., Bennett R.M., Bombardier C., Goldenberg D.L., et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990, 33:160-172.
3. Wolfe F., Ross K., Anderson J., Russell I.J., Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995, 38:19-28.
4. Clauw D.J. Fibromyalgia: an overview. Am J Med 2009, 122:S3-S13.
5. Clauw D.J., Arnold L.M., McCarberg B.H. The science of fibromyalgia. Mayo Clin Proc 2011, 86:907-911.
6. Wallace D.J., Linker-Israeli M., Hallegua D., Silverman S., Silver D., Weisman M.H. Cytokines play an aetiopathogenetic role in fibromyalgia: a hypothesis and pilot study. Rheumatology (Oxford) 2001, 40:743-749.
7. García J.J., Cidoncha A., Bote M.E., Hinchado M.D., Ortega E. Altered profile of chemokines in fibromyalgia patients. Ann Clin Biochem 2013, [Epub ahead of print].
8. Hader N. Altered interleukin-2. Arthritis Rheum 1991, 34(7):866-872.
9. Pillemer S.R. The neuroscience and endocrinology of fibromyalgia. Arthritis Rheum 1997, 40(11):1928-1939.
10. Dinarello C.A. Proinflammatory cytokines. Chest 2000, 118:503-508.
11. Wang X., Lupardus P., Laporte S.L., Garcia K.C. Structural biology of shared cytokine receptors. Annu Rev Immunol 2009, 27:29-60.
12. Charo I.F., Ransohoff R.M. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 2006, 354:610-621.
13. Ahrens C., Schiltenwolf M., Wang H. Cytokines in psychoneuroendocrine immunological context of nonspecific musculoskeletal pain. Schmerz 2012, 26:383-388.
14. Kiguchi N., Kobayashi Y., Kishioka S. Chemokines and cytokines in neuroinflammation leading to neuropathic pain. Curr Opin Pharmacol 2012, 12:55-61.
15. Wolf G., Gabay E., Tal M., Yirmiya R., Shavit Y. Genetic impairment of interleukin-1 signaling attenuates neuropathic pain, autotomy, and spontaneous ectopic neuronal activity, following nerve injury in mice. Pain 2006, 120:315-324.
16. Ramer M.S., Murphy P.G., Richardson P.M., Bisby M.A. Spinal nerve lesion-induced mechanoallodynia and adrenergic sprouting in sensory ganglia are attenuated in interleukin-6 knockout mice. Pain 1998, 78:115-121.
17. Malcangio M., Bowery N.G., Flower R.J., Perretti M. Effect of interleukin-1 beta on the release of substance P from rat isolated spinal cord. Eur J Pharmacol 1996, 299:113-118.
18. Janik J.E., Miller L.L., Longo D.L., Powers G.C., Urba W.J., Kopp W.C., et al. Phase II trial of interleukin 1 alpha and indomethacin in treatment of metastatic melanoma. J Natl Cancer Inst 1996, 88:44-49.
19. Bazzichi L., Giacomelli C., De Feo F., Giuliano T., Rossi A., Doveri M., et al. Antipolymer antibody in Italian fibromyalgic patients. Arthritis Res Ther 2007, 9:R86.
20. Wang H., Moser M., Schiltenwolf M., Buchner M. Circulating cytokine levels compared to pain in patients with fibromyalgia - a prospective longitudinal study over 6 months. J Rheumatol 2008, 35:1366-1370.
21. Gür A., Denli A., Karakoç M., Nas K. Cytokines and depression in cases with fibromyalgia. J Rheumatol 2002, 29:358-361.
22. Uçeyler N., Valenza R., Stock M., Schedel R., Sprotte G., Sommer C. Reduced levels of antiinflammatory cytokines in patients with chronic widespread pain. Arthritis Rheum 2006, 54:2656-2664.
23. Pay S., Calgüneri M., Calişkaner Z., Dinç A., Apraş S., Ertenli I., et al. Evaluation of vascular injury with proinflammatory cytokines, thrombomodulin and fibronectin in patients with primary fibromyalgia. Nagoya J Med Sci 2000, 63:115-122.
24. Uçeyler N., Häuser W., Sommer C. Systematic review with meta-analysis: cytokines in fibromyalgia syndrome. BMC Musculoskelet Disord 2011, 12:245.
25. Kadetoff D., Lampa J., Westman M., Andersson M., Kosek E. Evidence of central inflammation in fibromyalgia-increased cerebrospinal fluid interleukin-8 levels. J Neuroimmunol 2012, 242:33-38.
26. Geiss A., Rohleder N., Anton F. Evidence for an association between an enhanced reactivity of interleukin-6 levels and reduced glucocorticoid sensitivity in patients with fibromyalgia. Psychoneuroendocrinology 2012, 37:671-684.
27. Pernambuco A.P., Schetino L.P.L., Alvim C.C., Murad C.M., Viana R.S., Carvalho L.S.C., et al. Increased levels of IL-17A in patients with fibromyalgia. Clin Exp Rheumatol 2013, 31(6 Suppl 79):60-63.
28. Abbadie C. Chemokines, chemokine receptors and pain. Trends Immunol 2005, 26:529-534.
29. Zhang Z., Cherryholmes G., Mao A., Marek C., Longmate J., Kalos M., et al. High plasma levels of MCP-1 and eotaxin provide evidence for an immunological basis of fibromyalgia. Exp Biol Med (Maywood) 2008, 233:1171-1180.
30. Yigit S., Inanir A., Tekcan A., Inanir S., Tural S., Ates O. Association between fibromyalgia syndrome and polymorphism of the IL-4 gene in a Turkish population. Gene 2013, 527:62-64.
31. Togo F., Natelson B.H., Adler G.K., Ottenweller J.E., Goldenberg D.L., Struzik Z.R., et al. Plasma cytokine fluctuations over time in healthy controls and patients with fibromyalgia. Exp Biol Med (Maywood) 2009, 234:232-240.
32. Iannuccelli C., Di Franco M., Alessandri C., Guzzo M.P., Croia C., Di Sabato F., et al. Pathophysiology of fibromyalgia: a comparison with the tension-type headache, a localized pain syndrome. Ann N Y Acad Sci 2010, 1193:78-83.